RGEN

AS OF

Nov 13, 04:59 PM (EDT)

Price

$150.55

Change

-$7.46 (-4.72%)

Capitalization

8.89B

104 days until earnings call

Intraday BUY SELL Signals

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

RGEN

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Repligen (RGEN) Earnings Date & Reports

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

RGEN is expected to report earnings to fall 3.50% to 44 cents per share on February 25

Q4'25

Est.

$0.44

Q3'25

Beat

by $0.04

Q2'25

Missed

by $0.02

Q1'25

Beat

by $0.04

Q4'24

Beat

by $0.03

The last earnings report on October 28 showed earnings per share of 46 cents, beating the estimate of 41 cents. With 304.42K shares outstanding, the current market capitalization sits at 8.89B.

View a ticker or compare two or three

Compare

Search For Dips Search For Dips

Annualized Return+49%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

RGEN

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RGEN showed earnings on October 28, 2025. You can read more about the earnings report here.

View AI-Driven Trading for RGEN

A.I. Advisor

published General Information

General Information

a developer of biologic drugs

Industry PharmaceuticalsOther

Profile

Fundamentals

Details

Industry

Biotechnology

Address

41 Seyon Street

Phone

+1 781 250-0111

Employees

1783

Web

https://www.repligen.com